Peter H. Wiernik
B C Decker, Jan 1, 2001 - Medical - 350 pages
Adult Leukemias summarizes advances in leukemia biology and treatment. It discusses the most successful treatments currently available and examines the remaining obstacles to a cure. Wierniks team at New York Medical College have done seminal work in clinical investigation as well as patient management in the leukemias. The subject lends itself particularly well to color illustrations, a key feature of the American Cancer Society Atlas of Clinical Oncology series . This book is an essential reference tool for medical and radiation oncologists, and hematologists.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Molecular Etiology and Pathogenesis of Leukemia
Morphology of Adult Acute and Chronic Leukemias
7 other sections not shown
Other editions - View all
acute leukemia acute lymphoblastic leukemia acute myelogenous leukemia acute myeloid leukemia acute promyelocytic leukemia adult acute allogeneic bone marrow anemia antibodies antigen associated ATRA autologous bcr-abl blast crisis bone marrow transplantation Cancer chemotherapy chromosome chronic lymphocytic leukemia chronic myelogenous leukemia chronic myeloid leukemia chronic phase Clin Oncol clinical CR rate cytarabine cytic cytogenetic cytoplasm daunorubicin detected diagnosis disease disorders donor dose expression extramedullary factors Figure fludarabine fusion gene genetic granulocyte transfusions granulocytic sarcoma Group Haematol hematologic hematopoietic immunophenotypic induction infection involved karyotype Leuk leukemic cells leukemic infiltration lymphoid lymphoma malignancies mature mg/m molecular monocytic morphologic mutations myelodysplastic neutrophils normal nuclear patients with acute patients with AML percent of patients peripheral blood phenotype platelet platelet transfusion prognosis protein randomized refractory relapse reported risk stem cell transplantation subtypes syndrome T-cell therapy tion trans transcription translocation treatment trial tumor versus